Novo Nordisk rebounds from 2024 lows as GLP-1 supply issues ease, partnerships expand, and valuation turns attractive. Find ...

Novo Nordisk shows strong fundamentals and long-term return potential despite valuation concerns and US pricing risks. Find ...

This would make amycretin a more effective than other weight loss drugs like Wegovy, where a trial found that patients lost ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...

A NEW ‘Ozempic pill’ leads to faster weight loss than the popular ‘skinny jabs’, studies have suggested. The new weight loss ...

Eli Lilly said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...

While the makers of Ozempic have stated that their GLP-1 medication was not made to be used as a weight loss drug, nor should ...

A new weight loss treatment that can be taken as either a daily pill or a weekly injection has shown very promising results ...

Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, investigator says.